PCRX FY 2014 Earnings — Pacira BioSciences, Inc. Revenue & Financial Results | Market Cap Arena

PCRXPacira BioSciences, Inc.

$982M

FY 2014 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$198M+131.1% YoY

Gross Profit

$120M60.8% margin

Operating Income

-$5M-2.6% margin

Net Income

-$14M-6.9% margin

EPS (Diluted)

$-0.39

Cash Flow

Operating Cash Flow

$25M

Free Cash Flow

$4M

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$326M

Total Liabilities

$155M

Stockholders' Equity

$171M

Cash & Equivalents

$158M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$198M	$86M	+131.1%
Gross Profit	$120M	$31M	+290.6%
Operating Income	-$5M	-$53M	+90.3%
Net Income	-$14M	-$64M	+78.5%